title: [Mexican treatment goals for plaque psoriasis].
abstract: Psoriasis is a chronic inflammatory disease with a worldwide prevalence between 6 and 39% in moderate to severe forms. In European countries like Germany and England was identified that only one third of patients with moderate to severe forms will receive systemic management, this fact motivated to integrate into Europe an international consensus on treatment goals with the aim of providing support to the dermatologist by algorithms that serve as a therapeutic guide that allows you to gain control short and long term effects of this disease. The European group met to develop the definitions of severity of psoriasis, treatment goals for moderate to severe disease, and optimization options and / or therapeutic transition than a paper published in 2011 was obtained. In Mexico a working group of experts on biological therapy (GTEB), made up of 10 members and an extended group of 150 dermatologists' voters in the country for the purpose of issuing Mexico's position on the proposals of the European group was formed. In this document the findings of the Working Group of Experts on Biological Therapy in Mexico are listed.
authors.affiliation: Servicio de Dermatología, Hospital Regional Lic. Adolfo López Mateos, ISSSTE, Ciudad de México, México. lorenaestradaaguilar@prodigy.net.mx.
authors.forename: Lorena
authors.initials: L
authors.lastname: Estrada-Aguilar
authors.forename: Mario
authors.initials: M
authors.lastname: Amaya-Guerra
authors.forename: Minerva
authors.initials: M
authors.lastname: Gómez-Flores
authors.forename: Esther
authors.initials: E
authors.lastname: Guevara-Sanginés
authors.forename: Fermín
authors.initials: F
authors.lastname: Jurado-Santacruz
authors.forename: Adriana
authors.initials: A
authors.lastname: Lopeztello-Santillán
authors.forename: César
authors.initials: C
authors.lastname: Maldonado-García
authors.forename: Mónica
authors.initials: M
authors.lastname: Rivera-Gómez
authors.forename: Norma
authors.initials: N
authors.lastname: Rodríguez-Martínez
authors.forename: Luis
authors.initials: L
authors.lastname: Vega-González
mesh_terms: D000359:Aftercare; D003131:Combined Modality Therapy; D003697:Delphi Technique; D003879:Dermatologic Agents / Q000627:therapeutic use; D006040:Goals; D006801:Humans; D008800:Mexico; D010789:Phototherapy; D011565:Psoriasis / Q000175:diagnosis / Q000628:therapy*; D012720:Severity of Illness Index
chemical_list: D003879:Dermatologic Agents
keywords: Biologic therapy; Psoriasis; Skin diseases